{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:11Z","timestamp":1784775791069,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Provincial Key Medical Disciplines Development Program","award":["JSDW202234"],"award-info":[{"award-number":["JSDW202234"]}]},{"name":"Livelihood Science and Technology Project of Jiuquan Science and Technology Bureau","award":["2024MA1071"],"award-info":[{"award-number":["2024MA1071"]}]},{"name":"Lianyungang Ageing Health Research Project","award":["L202304"],"award-info":[{"award-number":["L202304"]}]},{"name":"Lianyungang Traditional Chinese Medicine Science and Technology Development Program Project","award":["ZD202310"],"award-info":[{"award-number":["ZD202310"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273167"],"award-info":[{"award-number":["82273167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05391-w","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:49:50Z","timestamp":1777434590000},"page":"15541-15555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alisertib exerts AURKA-independent antitumor activity in colon cancer by modulating immune-related pathways"],"prefix":"10.1007","volume":"399","author":[{"given":"Qi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zien","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"10","key":"5391_CR1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1158\/2159-8290.CD-24-0096","volume":"14","author":"S Acharya","year":"2024","unstructured":"Acharya S, Basar R, Daher M, Rafei H, Li P, Uprety N, Ensley E, Shanley M, Kumar B, Banerjee PP, Melo Garcia L, Lin P, Mohanty V, Kim KH, Jiang X, Pan Y, Li Y, Liu B, Nunez Cortes AK, Zhang C, Fathi M, Rezvan A, Montalvo MJ, Cha SL, Reyes-Silva F, Shrestha R, Guo X, Kundu K, Biederstadt A, Muniz-Feliciano L, Deyter GM, Kaplan M, Jiang XR, Liu E, Jain A, Roszik J, Fowlkes NW, Solis Soto LM, Raso MG, Khoury JD, Lin P, Vega F, Varadarajan N, Chen K, Marin D, Shpall EJ, Rezvani K (2024) CD28 costimulation augments CAR signaling in NK cells via the LCK\/CD3zeta\/ZAP70 signaling axis. Cancer Discov 14(10):1879\u20131900. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0096","journal-title":"Cancer Discov"},{"key":"5391_CR2","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201726","author":"IA Asteriti","year":"2023","unstructured":"Asteriti IA, Polverino F, Stagni V, Sterbini V, Ascanelli C, Naso FD, Mastrangelo A, Rosa A, Paiardini A, Lindon C, Guarguaglini G (2023) AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.202201726","journal-title":"Life Sci Alliance"},{"issue":"12","key":"5391_CR3","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1021\/acs.jcim.4c00387","volume":"64","author":"F Bravo-Moraga","year":"2024","unstructured":"Bravo-Moraga F, Bedoya M, Vergara-Jaque A, Alzate-Morales J (2024) Understanding the differences of Danusertib\u2019s residence time in Aurora Kinases A\/B: dissociation paths and key residues identified using conventional and enhanced molecular dynamics simulations. J Chem Inf Model 64(12):4759\u20134772. https:\/\/doi.org\/10.1021\/acs.jcim.4c00387","journal-title":"J Chem Inf Model"},{"issue":"1","key":"5391_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2282184","volume":"56","author":"M Chen","year":"2024","unstructured":"Chen M, Zhu H, Li J, Luo D, Zhang J, Liu W, Wang J (2024) Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA. Ann Med 56(1):2282184. https:\/\/doi.org\/10.1080\/07853890.2023.2282184","journal-title":"Ann Med"},{"key":"5391_CR5","doi-asserted-by":"publisher","first-page":"1549102","DOI":"10.3389\/fimmu.2025.1549102","volume":"16","author":"D Dai","year":"2025","unstructured":"Dai D, Cao G, Huang S, Xu M, Wang J, Han X, Ma Q, Lin J (2025) Porphyromonas gingivalis exacerbates experimental autoimmune encephalomyelitis by driving Th1 differentiation via ZAP70\/NF-kappaB signaling. Front Immunol 16:1549102. https:\/\/doi.org\/10.3389\/fimmu.2025.1549102","journal-title":"Front Immunol"},{"issue":"10","key":"5391_CR6","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/annonc\/mdw281","volume":"27","author":"MA Dickson","year":"2016","unstructured":"Dickson MA, Mahoney MR, Tap WD, D\u2019Angelo SP, Keohan ML, Van Tine BA, Agulnik M, Horvath LE, Nair JS, Schwartz GK (2016) Phase II study of MLN8237 (Alisertib) in advanced\/metastatic sarcoma. Ann Oncol 27(10):1855\u20131860. https:\/\/doi.org\/10.1093\/annonc\/mdw281","journal-title":"Ann Oncol"},{"issue":"1","key":"5391_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20(1):15. https:\/\/doi.org\/10.1186\/s12943-020-01305-3","journal-title":"Mol Cancer"},{"issue":"6","key":"5391_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/1440-1681.12571","volume":"43","author":"CT Durlacher","year":"2016","unstructured":"Durlacher CT, Li ZL, Chen XW, He ZX, Zhou SF (2016) An update on the pharmacokinetics and pharmacodynamics of Alisertib, a selective Aurora kinase A inhibitor. Clin Exp Pharmacol Physiol 43(6):585\u2013601. https:\/\/doi.org\/10.1111\/1440-1681.12571","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"5391_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clcc.2022.05.006","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas JC, Ramnaraign B, George TJ (2022) Clinical updates for colon cancer care in 2022. Clin Colorectal Cancer 21(3):198\u2013203. https:\/\/doi.org\/10.1016\/j.clcc.2022.05.006","journal-title":"Clin Colorectal Cancer"},{"issue":"13","key":"5391_CR10","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1093\/hmg\/ddw128","volume":"25","author":"JE Fellmeth","year":"2016","unstructured":"Fellmeth JE, Ghanaim EM, Schindler K (2016) Characterization of macrozoospermia-associated AURKC mutations in a mammalian meiotic system. Hum Mol Genet 25(13):2698\u20132711. https:\/\/doi.org\/10.1093\/hmg\/ddw128","journal-title":"Hum Mol Genet"},{"issue":"42","key":"5391_CR11","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.3748\/wjg.v30.i42.4566","volume":"30","author":"DJ Flynn","year":"2024","unstructured":"Flynn DJ, Feuerstein JD (2024) Colon cancer screening programs prevent cancer. World J Gastroenterol 30(42):4566\u20134568. https:\/\/doi.org\/10.3748\/wjg.v30.i42.4566","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5391_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.27137","volume":"99","author":"D Ghergus","year":"2024","unstructured":"Ghergus D, Martin M, Knapp AM, Delmotte F, Joublin-Delavat A, Jung S, Schickel JN, Mendel I, Dupuis A, Drenou B, Ghesquieres H, Salles G, Baseggio L, Herbrecht R, Korganow AS, Vallat L, Soulas-Sprauel P, Meffre E, Martin T (2024) Normal B cells express ZAP70 in chronic lymphocytic leukemia: a link between autoimmunity and lymphoproliferation? Am J Hematol 99(1):48\u201356. https:\/\/doi.org\/10.1002\/ajh.27137","journal-title":"Am J Hematol"},{"issue":"1","key":"5391_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, Wang W, Chen L, Ding Z, Zhang P (2025) Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med 8(1):796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2","journal-title":"NPJ Digit Med"},{"issue":"6","key":"5391_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jamaoncol.2022.7949","volume":"9","author":"TC Haddad","year":"2023","unstructured":"Haddad TC, Suman VJ, D\u2019Assoro AB, Carter JM, Giridhar KV, McMenomy BP, Santo K, Mayer EL, Karuturi MS, Morikawa A, Marcom PK, Isaacs CJ, Oh SY, Clark AS, Mayer IA, Keyomarsi K, Hobday TJ, Peethambaram PP, O\u2019Sullivan CC, Leon-Ferre RA, Liu MC, Ingle JN, Goetz MP (2023) Evaluation of Alisertib alone or combined with Fulvestrant in patients with endocrine-resistant advanced breast cancer: the phase 2 TBCRC041 randomized clinical trial. JAMA Oncol 9(6):815\u2013824. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7949","journal-title":"JAMA Oncol"},{"key":"5391_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071446","author":"Y Hatano","year":"2017","unstructured":"Hatano Y, Fukuda S, Hisamatsu K, Hirata A, Hara A, Tomita H (2017) Multifaceted interpretation of colon cancer stem cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18071446","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5391_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3892\/mmr.2020.11171","volume":"22","author":"D Hu","year":"2020","unstructured":"Hu D, Zhang B, Yu M, Shi W, Zhang L (2020) Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network. Mol Med Rep 22(2):620\u2013632. https:\/\/doi.org\/10.3892\/mmr.2020.11171","journal-title":"Mol Med Rep"},{"key":"5391_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/1471-2407-12-563","volume":"12","author":"M Khateb","year":"2012","unstructured":"Khateb M, Ruimi N, Khamisie H, Najajreh Y, Mian A, Metodieva A, Ruthardt M, Mahajna J (2012) Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism. BMC Cancer 12:563. https:\/\/doi.org\/10.1186\/1471-2407-12-563","journal-title":"BMC Cancer"},{"issue":"1159","key":"5391_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/bjr\/tqae061","volume":"97","author":"MJ Lahaye","year":"2024","unstructured":"Lahaye MJ, Lambregts DMJ, Aalbers AGJ, Snaebjornsson P, Beets-Tan RGH, Kok NFM (2024) Imaging in the era of risk-adapted treatment in colon cancer. Br J Radiol 97(1159):1214\u20131221. https:\/\/doi.org\/10.1093\/bjr\/tqae061","journal-title":"Br J Radiol"},{"key":"5391_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110331","volume":"94","author":"E Leveille","year":"2022","unstructured":"Leveille E, Chan LN, Mirza AS, Kume K, Muschen M (2022) SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies. Cell Signal 94:110331. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110331","journal-title":"Cell Signal"},{"issue":"12","key":"5391_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18475","volume":"28","author":"J Li","year":"2024","unstructured":"Li J, Cheng C, Zhang J (2024) An analysis of AURKB\u2019s prognostic and immunological roles across various cancers. J Cell Mol Med 28(12):e18475. https:\/\/doi.org\/10.1111\/jcmm.18475","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5391_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13543784.2018.1417382","volume":"27","author":"S Liewer","year":"2018","unstructured":"Liewer S, Huddleston A (2018) Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors. Expert Opin Investig Drugs 27(1):105\u2013112. https:\/\/doi.org\/10.1080\/13543784.2018.1417382","journal-title":"Expert Opin Investig Drugs"},{"key":"5391_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1182601","volume":"14","author":"B Meng","year":"2023","unstructured":"Meng B, Zhao X, Jiang S, Xu Z, Li S, Wang X, Ma W, Li L, Liu D, Zheng J, Peng H, Shi M (2023) AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses. Front Immunol 14:1182601. https:\/\/doi.org\/10.3389\/fimmu.2023.1182601","journal-title":"Front Immunol"},{"key":"5391_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-pharmtox-022123-104147","volume":"64","author":"V Oleinikovas","year":"2024","unstructured":"Oleinikovas V, Gainza P, Ryckmans T, Fasching B, Thoma NH (2024) From Thalidomide to rational molecular glue design for targeted protein degradation. Annu Rev Pharmacol Toxicol 64:291\u2013312. https:\/\/doi.org\/10.1146\/annurev-pharmtox-022123-104147","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"5391_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.14348\/molcells.2018.2311","volume":"41","author":"JW Park","year":"2018","unstructured":"Park JW, Cho H, Oh H, Kim JY, Seo SB (2018) AURKA suppresses leukemic THP-1 cell differentiation through inhibition of the KDM6B pathway. Mol Cells 41(5):444\u2013453. https:\/\/doi.org\/10.14348\/molcells.2018.2311","journal-title":"Mol Cells"},{"issue":"1","key":"5391_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12885-022-09458-8","volume":"22","author":"L Ren","year":"2022","unstructured":"Ren L, Li P, Li Z, Chen Q (2022) AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells. BMC Cancer 22(1):465. https:\/\/doi.org\/10.1186\/s12885-022-09458-8","journal-title":"BMC Cancer"},{"issue":"1","key":"5391_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cbdd.13850","volume":"98","author":"K Sankhe","year":"2021","unstructured":"Sankhe K, Prabhu A, Khan T (2021) Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer. Chem Biol Drug des 98(1):73\u201393. https:\/\/doi.org\/10.1111\/cbdd.13850","journal-title":"Chem Biol Drug des"},{"issue":"2","key":"5391_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00280-021-04293-3","volume":"88","author":"TJ Semrad","year":"2021","unstructured":"Semrad TJ, Kim EJ, Gong IY, Li T, Christensen S, Arora M, Riess JW, Gandara DR, Kelly K (2021) Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors. Cancer Chemother Pharmacol 88(2):335\u2013341. https:\/\/doi.org\/10.1007\/s00280-021-04293-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"5391_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.critrevonc.2017.09.006","volume":"119","author":"Y Tayyar","year":"2017","unstructured":"Tayyar Y, Jubair L, Fallaha S, McMillan NAJ (2017) Critical risk-benefit assessment of the novel anti-cancer aurora a kinase inhibitor alisertib (MLN8237): a comprehensive review of the clinical data. Crit Rev Oncol Hematol 119:59\u201365. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.09.006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"5391_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.48095\/ccrvch202597","volume":"104","author":"J Tomasek","year":"2025","unstructured":"Tomasek J, Fiala L (2025) Colon cancer - neoadjuvant treatment of non-metastatic disease. Rozhl Chir 104(3):97\u2013100. https:\/\/doi.org\/10.48095\/ccrvch202597","journal-title":"Rozhl Chir"},{"issue":"5","key":"5391_CR30","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia W, Liu J, Chen R, Feng J, Wu L, Wang Y, Wang X, Song C, Mao W (2025) Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin J Cancer Res 37(5):796\u2013820. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.05.11","journal-title":"Chin J Cancer Res"},{"issue":"11","key":"5391_CR31","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3324\/haematol.2023.284873","volume":"109","author":"Y Xu","year":"2024","unstructured":"Xu Y, Jia P, Li Y, Zhang H, Zhang J, Li W, Zhen Y, Li Y, Cao J, Zheng T, Wang Y, Liu Y, An X, Zhang S (2024) A novel role of AURKA kinase in erythroblast enucleation. Haematologica 109(11):3721\u20133734. https:\/\/doi.org\/10.3324\/haematol.2023.284873","journal-title":"Haematologica"},{"key":"5391_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.omtn.2018.08.014","volume":"13","author":"K Zhang","year":"2018","unstructured":"Zhang K, Wang T, Zhou H, Feng B, Chen Y, Zhi Y, Wang R (2018) A novel Aurora-A inhibitor (MLN8237) synergistically enhances the antitumor activity of Sorafenib in hepatocellular carcinoma. Mol Ther Nucleic Acids 13:176\u2013188. https:\/\/doi.org\/10.1016\/j.omtn.2018.08.014","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"5391_CR33","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, Huang Y, Liu J, Huang C, Luo P (2025) Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res 37(6):1000\u20131019. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.06.11","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"5391_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jcph.1958","volume":"62","author":"X Zhou","year":"2022","unstructured":"Zhou X, Mould DR, Yuan Y, Fox E, Greengard E, Faller DV, Venkatakrishnan K (2022) Population pharmacokinetics and exposure-safety relationships of Alisertib in children and adolescents with advanced malignancies. J Clin Pharmacol 62(2):206\u2013219. https:\/\/doi.org\/10.1002\/jcph.1958","journal-title":"J Clin Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05391-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:59:58Z","timestamp":1784775598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05391-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5391"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05391-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in accordance with the relevant guidelines and regulations. All animal experimental protocols were approved by the Ethics Committee of Jiangsu Ocean University (Approval No. Jou2025052106; Date of approval: May 21, 2025). All efforts were made to minimize animal suffering and the number of animals used.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}